Quarterly Results

  • Company Name :
Parmax Pharma Ltd Industry : (Pharmaceuticals)
  • BSE Code:
  • 540359
  • NSE Symbol:
  • -
  • P/E(TTM):
  • -
  • ISIN Demat:
  • INE240T01014
  • Div & Yield%:
  • -
  • EPS(TTM):
  • -
  • Book Value(₹):
  • -7.21
  • Market Cap(₹Cr.):
  • 14.22
  • Face Value(₹):
  • 10.00
Quarters :  
Particulars March 2025 ( Cr)December 2024 ( Cr)September 2024 ( Cr)
Gross Sales 4.83 6.28 9.28
Excise Duty 0.00 0.00 0.00
Net Sales 4.83 6.28 9.28
Other Operating Income 0.00 0.00 0.00
Other Income -0.10 0.01 0.12
Total Income 4.73 6.30 9.39
Total Expenditure 6.46 6.18 9.08
PBIDT -1.74 0.12 0.32
Interest 0.24 0.11 0.13
PBDT -1.97 0.01 0.19
Depreciation -0.18 0.41 0.40
Tax 0.00 0.00 0.00
Fringe Benefit Tax 0.00 0.00 0.00
Deferred Tax -0.30 0.00 0.00
Reported Profit After Tax -1.49 -0.39 -0.22
Extra-ordinary Items -1.07 0.00 0.00
Adjusted Profit After Extra-ordinary item -0.42 -0.39 -0.22
EPS (Unit Curr.) -4.00 -1.05 -0.58
EPS (Adj) (Unit Curr.) -4.00 -1.05 -0.58
Calculated EPS (Unit Curr.) -4.00 -1.05 -0.58
Calculated EPS (Adj) (Unit Curr.) -4.00 -1.05 -0.58
Calculated EPS (Ann.) (Unit Curr.) -15.98 -4.22 -2.32
Calculated EPS (Adj) (Ann.) (Unit Curr.) -15.98 -4.22 -2.32
Book Value (Unit Curr.) 0.00 0.00 0.00
Dividend (%) 0.00 0.00 0.00
Equity 3.74 3.74 3.74
Reserve & Surplus 0.00 0.00 0.00
Face Value 10.00 10.00 10.00
Public Shareholding (No. Of Shares) 0.00 0.00 0.00
Public Shareholding (% in Equity) 0.00 0.00 0.00
Pledged/Encumbered - No. of Shares 0.00 0.00 0.00
Pledged/Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Pledged/Encumbered - % in Total Equity 0.00 0.00 0.00
Non Encumbered - No. of Shares 0.00 0.00 0.00
Non Encumbered - % in Total Promoters Holding 0.00 0.00 0.00
Non Encumbered - % in Total Equity 0.00 0.00 0.00
PBIDTM(%) -36.02 1.91 3.45
PBDTM(%) -40.79 0.16 2.05
PATM(%) -30.85 -6.21 -2.37